Insider Transactions in Q2 2023 at Hcw Biologics Inc. (HCWB)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 09
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+3.55%
|
$40,000
$2.06 P/Share
|
Jun 08
2023
|
Lee Flowers SVP of Business Development |
BUY
Open market or private purchase
|
Direct |
10,000
+8.24%
|
$20,000
$2.16 P/Share
|
Jun 08
2023
|
Lee Flowers SVP of Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,356
+5.02%
|
$0
$0.14 P/Share
|
Jun 08
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,696
+0.89%
|
$9,392
$2.21 P/Share
|
Jun 07
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+3.71%
|
$40,000
$2.03 P/Share
|
Jun 06
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
19,062
+3.68%
|
$19,062
$1.82 P/Share
|
Jun 05
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+4.0%
|
$20,000
$1.67 P/Share
|
Jun 02
2023
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
800
+0.01%
|
$800
$1.54 P/Share
|
Jun 01
2023
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
800
+0.01%
|
$800
$1.62 P/Share
|
May 31
2023
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.01%
|
$2,000
$1.55 P/Share
|
May 31
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
500
+3.37%
|
$500
$1.5 P/Share
|
May 30
2023
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+0.02%
|
$3,000
$1.55 P/Share
|
May 30
2023
|
Gary M Winer |
BUY
Open market or private purchase
|
Direct |
850
+5.78%
|
$850
$1.52 P/Share
|
May 26
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+4.17%
|
$20,000
$1.66 P/Share
|
May 25
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+4.35%
|
$20,000
$1.62 P/Share
|
May 24
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+4.54%
|
$20,000
$1.61 P/Share
|
May 23
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,036
+1.24%
|
$5,036
$1.57 P/Share
|
May 22
2023
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
33,450
+7.8%
|
$33,450
$1.53 P/Share
|